Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valentina Tini

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
BMC Bioinformatics|December 22, 2020
ARPIR: automatic RNA-Seq pipelines with interactive reportGiulio Spinozzi, Valentina Tini, Alessia Adorni, et al.
Haematologica|July 28, 2022
Acute myeloid leukemia development soon after anti-CD19 chimeric antigen receptor T-cell infusion in a patient with refractory diffuse large B-cell lymphoma and pre-existing clonal hematopoiesisLorenza Falini, Alessandra Venanzi, Valentina Tini, et al.
Biomolecules|July 27, 2022
SiCoDEA: A Simple, Fast and Complete App for Analyzing the Effect of Individual Drugs and Their CombinationsGiulio Spinozzi, Valentina Tini, Alessio Ferrari, et al.
Blood Advances|August 29, 2022
Prolonged XPO1 inhibition is essential for optimal antileukemic activity in NPM1-mutated AMLGiulia Pianigiani, Andrea Gagliardi, Federica Mezzasoma, et al.
Blood Advances|February 14, 2022
Metalloproteinase inhibition reduces AML growth, prevents stem cell loss, and improves chemotherapy effectivenessChiara Pirillo, Flora Birch, Floriane S Tissot, et al.
Frontiers in Oncology|October 11, 2023
<i>NOTCH1</i>-mutated chronic lymphocytic leukemia displays high endoplasmic reticulum stress response with druggable potentialEstevão Carlos Silva Barcelos, Chiara Rompietti, Francesco Maria Adamo, et al.
Leukemia|November 7, 2020
Bcor deficiency perturbs erythro-megakaryopoiesis and cooperates with Dnmt3a loss in acute erythroid leukemia onset in micePaolo Sportoletti, Daniele Sorcini, Anna G Guzman, et al.
Blood Advances|December 15, 2022
IL-3-zetakine combined with a CD33 costimulatory receptor as a dual CAR approach for safer and selective targeting of AMLVincenzo Maria Perriello, Maria Caterina Rotiroti, Ilaria Pisani, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
BMC Bioinformatics|December 22, 2020
ARPIR: automatic RNA-Seq pipelines with interactive reportGiulio Spinozzi, Valentina Tini, Alessia Adorni, et al.
Haematologica|July 28, 2022
Acute myeloid leukemia development soon after anti-CD19 chimeric antigen receptor T-cell infusion in a patient with refractory diffuse large B-cell lymphoma and pre-existing clonal hematopoiesisLorenza Falini, Alessandra Venanzi, Valentina Tini, et al.
Biomolecules|July 27, 2022
SiCoDEA: A Simple, Fast and Complete App for Analyzing the Effect of Individual Drugs and Their CombinationsGiulio Spinozzi, Valentina Tini, Alessio Ferrari, et al.
Blood Advances|August 29, 2022
Prolonged XPO1 inhibition is essential for optimal antileukemic activity in NPM1-mutated AMLGiulia Pianigiani, Andrea Gagliardi, Federica Mezzasoma, et al.
Blood Advances|February 14, 2022
Metalloproteinase inhibition reduces AML growth, prevents stem cell loss, and improves chemotherapy effectivenessChiara Pirillo, Flora Birch, Floriane S Tissot, et al.
Frontiers in Oncology|October 11, 2023
<i>NOTCH1</i>-mutated chronic lymphocytic leukemia displays high endoplasmic reticulum stress response with druggable potentialEstevão Carlos Silva Barcelos, Chiara Rompietti, Francesco Maria Adamo, et al.
Leukemia|November 7, 2020
Bcor deficiency perturbs erythro-megakaryopoiesis and cooperates with Dnmt3a loss in acute erythroid leukemia onset in micePaolo Sportoletti, Daniele Sorcini, Anna G Guzman, et al.
Blood Advances|December 15, 2022
IL-3-zetakine combined with a CD33 costimulatory receptor as a dual CAR approach for safer and selective targeting of AMLVincenzo Maria Perriello, Maria Caterina Rotiroti, Ilaria Pisani, et al.
Pageof 1